Times Square Capital Management, LLC Novo Cure LTD Transaction History

Times Square Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$130.4 - $225.58 $7.92 Million - $13.7 Million	-60,700 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $1.09 Million - $1.67 Million	-8,800 Reduced 12.66%	60,700 $8.02 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $8.13 Million - $12.6 Million	-72,500 Reduced 51.06%	69,500 $12 Million
Q3 2020 Nov 06, 2020	SELL	$58.05 - $111.31 $4.52 Million - $8.67 Million	-77,900 Reduced 35.43%	142,000 $15.8 Million
Q2 2020 Aug 07, 2020	BUY	$57.2 - $74.41 $1.89 Million - $2.46 Million	33,000 Added 17.66%	219,900 $13 Million
Q1 2020 May 08, 2020	SELL	$57.05 - $95.75 $12.8 Million - $21.6 Million	-225,100 Reduced 54.64%	186,900 $12.6 Million
Q4 2019 Feb 05, 2020	SELL	$68.3 - $93.8 $5.12 Million - $7.04 Million	-75,000 Reduced 15.4%	412,000 $34.7 Million
Q3 2019 Nov 05, 2019	SELL	$61.86 - $97.8 $24.9 Million - $39.4 Million	-403,015 Reduced 45.28%	487,000 $36.4 Million
Q2 2019 Aug 02, 2019	SELL	$42.22 - $63.23 $4.15 Million - $6.22 Million	-98,375 Reduced 9.95%	890,015 $56.3 Million
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $9.37 Million - $16.5 Million	-293,285 Reduced 22.88%	988,390 $47.6 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $2.85 Million - $5.22 Million	99,150 Added 8.38%	1,281,675 $42.9 Million
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $9.71 Million - $15.9 Million	-303,375 Reduced 20.42%	1,182,525 $0
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $29.5 Million - $47.5 Million	1,485,900 New	1,485,900 $46.5 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.